Neoadjuvant Immuno-Chemotherapy: A New Perspective for Stage III NSCLC?

BACKGROUND: Stage III Non-small cell lung cancer (NSCLC) is a heterogenous disease with novel treatment options. Recently, immunotherapy has attracted a lot of attention for advanced NSCLC. OBJECTIVE: The objective of our study was to assess the efficacy and safety of neoadjuvant immuno-chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yuanshan, Tang, Dongfang, Gao, Wen, Zhang, Huibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018103/
https://www.ncbi.nlm.nih.gov/pubmed/35449550
http://dx.doi.org/10.3389/fsurg.2022.843987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018103/
https://www.ncbi.nlm.nih.gov/pubmed/35449550
http://dx.doi.org/10.3389/fsurg.2022.843987

Ejemplares similares